Oct. 27 (Bloomberg) -- Novo Nordisk A/S gained as much as 5.7 percent in Copenhagen trading after raising the lower end of its full-year outlook in local currencies.

To contact the editor responsible for this story: Frances Schwartzkopff at fschwartzko1@bloomberg.net